The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (nature.com)

Authors: Jin P … Li J Journal: Nature Communications Published: 2026-08-07 DOI: https://doi.org/10.1038/s41467-026-76313-w